Showing results (271-280 of 280) with videos related to
Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 280 results.
Oncoimmunology|October 25, 2019
Constitutively active GSK3β as a means to bolster dendritic cell functionality in the face of tumour-mediated immune suppressionMarta López González, Dinja Oosterhoff, Jelle J Lindenberg, et al.Journal of Experimental & Clinical Cancer Research : CR|November 7, 2024
Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumorsElise Jirovec, Dafne C A Quixabeira, James H A Clubb, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 15, 2026
Fully intravenous split-dose administration of the oncolytic adenovirus TILT-123 in advanced solid tumorsElise Jirovec, Katriina J Jalkanen, Dafne C A Quixabeira, et al.Frontiers in Immunology|February 23, 2023
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive settingJames H A Clubb, Tatiana V Kudling, Mykhailo Girych, et al.Cell Reports. Medicine|March 19, 2025
Safety and efficacy of combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus TILT-123 in metastatic melanomaTine J Monberg, Santeri A Pakola, Benedetta Albieri, et al.Nature Communications|February 5, 2025
The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trialMatthew Stephen Block, James Hugo Armstrong Clubb, Johanna Mäenpää, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026
Dyslipidaemia-associated natural IgM improves oncolytic virus TILT-123 efficacy through antibody-dependent enhancement in solid tumoursJames Hugo Armstrong Clubb, Santeri Artturi Pakola, Sakari Joenväärä, et al.Journal for Immunotherapy of Cancer|March 27, 2020
Consensus guidelines for the definition, detection and interpretation of immunogenic cell deathLorenzo Galluzzi, Ilio Vitale, Sarah Warren, et al.Frontiers in Immunology|December 5, 2015
Molecular and Translational Classifications of DAMPs in Immunogenic Cell DeathAbhishek D Garg, Lorenzo Galluzzi, Lionel Apetoh, et al.Oncoimmunology|May 6, 2015
Consensus guidelines for the detection of immunogenic cell deathOliver Kepp, Laura Senovilla, Ilio Vitale, et al.Pageof 28